How are DHR strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the DHR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.56%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$870.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a DHR strangle?

The breakeven for the DHR strangle priced on this page is roughly $171.30 and $208.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DHR market-implied 1-standard-deviation expected move is approximately 10.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current DHR implied volatility affect this strangle?

DHR ATM IV is at 37.56% with IV rank near 79.93%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.

DHR Strangle Strategy

DHR (Danaher Corporation), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers.

DHR (Danaher Corporation) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $138.49B, a trailing P/E of 37.55, a beta of 0.83 versus the broader market, a 52-week range of 160.93-242.8, average daily share volume of 4.6M, a public-listing history dating back to 1978, approximately 61K full-time employees. These structural characteristics shape how DHR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.83 places DHR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 37.55 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. DHR pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on DHR?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current DHR snapshot

As of June 30, 2026, spot at $190.82, ATM IV 37.56%, IV rank 79.93%, expected move 10.77%. The strangle on DHR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.

Why this strangle structure on DHR specifically: DHR IV at 37.56% is rich versus its 1-year range, which makes a premium-buying DHR strangle relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 10.77% (roughly $20.55 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DHR expiries trade a higher absolute premium for lower per-day decay. Position sizing on DHR should anchor to the underlying notional of $190.82 per share and to the trader's directional view on DHR stock.

DHR strangle setup

The DHR strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DHR near $190.82, the first option leg uses a $200.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DHR chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DHR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$200.00	$4.90
Buy 1	Put	$180.00	$3.80

DHR strangle risk and reward

Net Premium / Debit: -$870.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$870.00
Breakeven(s): $171.30, $208.70
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

DHR strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on DHR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$17,129.00
$42.20	-77.9%	+$12,909.97
$84.39	-55.8%	+$8,690.95
$126.58	-33.7%	+$4,471.92
$168.77	-11.6%	+$252.90
$210.96	+10.6%	+$226.13
$253.15	+32.7%	+$4,445.15
$295.34	+54.8%	+$8,664.18
$337.53	+76.9%	+$12,883.20
$379.72	+99.0%	+$17,102.23

When traders use strangle on DHR

Strangles on DHR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the DHR chain.

DHR thesis for this strangle

The market-implied 1-standard-deviation range for DHR extends from approximately $170.27 on the downside to $211.37 on the upside. A DHR long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current DHR IV rank near 79.93% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on DHR at 37.56%. As a Healthcare name, DHR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DHR-specific events.

DHR strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DHR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DHR alongside the broader basket even when DHR-specific fundamentals are unchanged. Always rebuild the position from current DHR chain quotes before placing a trade.

Frequently asked questions

What is a strangle on DHR?: A strangle on DHR is the strangle strategy applied to DHR (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With DHR stock trading near $190.82, the strikes shown on this page are snapped to the nearest listed DHR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are DHR strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the DHR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 37.56%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$870.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DHR strangle?: The breakeven for the DHR strangle priced on this page is roughly $171.30 and $208.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DHR market-implied 1-standard-deviation expected move is approximately 10.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on DHR?: Strangles on DHR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the DHR chain.
How does current DHR implied volatility affect this strangle?: DHR ATM IV is at 37.56% with IV rank near 79.93%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.